A carregar...
Predictive Biomarkers and Companion Diagnostics. The Future of Immunohistochemistry – ‘in situ proteomics’, or just a ‘stain’?
A ‘companion diagnostic’ is a test for a predictive biomarker, that classifies patients (tumors) into responders and non-responders, for a specified therapeutic agent. Companion diagnostics are designated as Class III medical devices by the FDA, because the test result equates directly to administra...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4215952/ https://ncbi.nlm.nih.gov/pubmed/25203298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAI.0000000000000126 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|